THE COVID-19 pandemic has forever changed the world's relationship to vaccines, spurring unprecedented production and innovation even while poorer nations were left behind.
At the start of World Immunization Week, AFP looks at the current state of play.
- Millions of lives saved -
Vaccines for more than 20 life-threatening diseases prevent between two to three million deaths a year, according to the World Health Organization.
Until COVID-19, vaccines tended to be targeted at specific groups, such as children, the elderly or vulnerable people.
And before the pandemic, the world produced around five billion total vaccine doses a year.
Then everything changed: 11 billion doses of COVID vaccines were produced in 2021 alone.
While vaccines against COVID were created in under a year, there are still no jabs for other infectious diseases like HIV that have been around for decades and killed millions.
The huge differences in vaccination rates between rich and poor countries has also shone a light on other vaccine inequalities.
Despite an effective measles vaccine being available for more than half a century, 140,000 deaths from the disease were recorded in 2018 mostly among children in developing countries, according to France's INSERM institute.
- Different technologies -
Since British physician Edward Jenner came up with the first vaccine in 1796 for smallpox, several different kinds have been developed.
Inactivated vaccines, which are used for polio and influenza, kill or inactivate the germ, but retain its ability to produce antibodies to fight future infections.
Attenuated vaccines used for measles, mumps and rubella as well as chickenpox contain a weakened version of the virus, again to boost antibodies.
More recently, viral vector vaccines, used for Ebola or AstraZeneca and Johnson & Johnson's COVID vaccines, take a modified version of a different, harmless virus to smuggle genetic instructions to the body's cells, telling them to make antibodies.
The newest technology is mRNA, used in Pfizer and Moderna's COVID vaccines, which delivers instructions to build the spike protein of the coronavirus, to evoke antibodies.
- mRNA 'shuffling the deck' -
Traditionally, only a few large pharmaceutical firms have had the capacity to develop new vaccines because of the huge costs involved.
"It was the preserve of a happy few. Messenger RNA is shuffling the deck," said Loic Plantevin, a healthcare expert at the Bain and Company consultancy.
Before the pandemic, four companies accounted for 90 percent of the global vaccine market: American giants Pfizer and Merck, Britain's GSK and France's Sanofi.
However, none except Pfizer thanks to a partnership with German firm BioNTech managed to quickly get a COVID vaccine to market.
But the rise of COVID has created new players in the field, such as mRNA vaccine leaders BioNTech and Moderna.
It has also spurred production in nations that missed out on the lion's share of vaccine doses earlier in the pandemic.
The WHO plans to set up mRNA vaccine production centres in six African countries as early as 2024.
Such projects have made possible by mRNA vaccines, which can be updated and developed more swiftly, while "traditional technologies remain complicated to deploy and relocate," Plantevin said.
Drew Weissman of the University of Pennsylvania, whose decades of research paved the way for mRNA technology, said his team has also been working to set up COVID vaccine production sites in Thailand and in several African countries.
"My overall goal is that if you have local production and local control, when COVID is over these vaccine sites will be able to make the vaccines that they need," Weissman told AFP.
"So Thailand will make dengue, Africa will make malaria those are vaccines that pharmaceuticals don't have much interest in."
- Malaria, HIV now targeted -
The rapid rollout of the flexible mRNA technology has also boosted hopes of new vaccines for other infectious diseases. Moderna is already targeting dengue fever, Ebola and malaria.
There are also numerous projects working on a universal coronavirus vaccine, that would protect not just against COVID and its variants, but against other future coronaviruses that could spread from animals.
And there are still hopes for the long-sought goal of an HIV vaccine.
Plantevin said "the pandemic has accelerated the pace and reminded (us) of the need to continue innovating in vaccines".
ETX Studio
Tue Apr 26 2022
Vaccines for more than 20 life-threatening diseases prevent between two to three million deaths a year, according to the World Health Organisation. - ETX Studio
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.
NFOF will be operational in November 2024 with funding of RM1 bil
PM Anwar Ibrahim said NFOF will support venture capital fund managers to invest in startup companies with RM300 million set aside for 2025.
Minimum wage to increase to RM1,700 effective Feb 1, 2025
The Progressive Wage Policy would be fully enforced next year with an allocation of RM200 million, benefiting 50,000 workers.
Bursa Malaysia ends higher on Budget 2025 optimism
The benchmark index, which opened 1.85 points higher at 1,643.29, moved between 1,641.71 and 1,649.31 throughout the trading session.
Five important aspects relating to people’s lives in Budget 2025 - PM
The focus is on driving the MADANI Economy, speeding reforms, cutting red tape, raising wages, and tackling the cost of living.
Economic outlook: Govt plans to leverage, expand existing city transit system
The expansion aims to provide a more efficient and reliable public transportation network, reduce congestion, and improve accessibility.
Economic outlook: Budget 2025 to lay foundation for a digital-driven economy
The report said Budget 2025 will entail efforts to position Kuala Lumpur as a top 20 global startup hub by 2030 through the KL20 initiative.
Economic outlook: Corruption and lack of accountability hinder economic progress
Special Cabinet Committee on National governance is established to curb corruption, law reforms to modernise outdate regulations, MoF said.
National Wages Consultative Council will be strengthened
The govt will also incentivise hiring women returning from career breaks, offer job matching and improve care services facilities.
Economic outlook: Ensuring 11 years of compulsory education for all children
Budget 2025 will continue prioritising upskilling and retraining initiatives to equip workers with the latest skill sets necessary.
Consolidated public sector projected to record lower surplus of RM41.7 bil 2024
The MoF said the consolidated general government revenue is estimated to increase slightly to RM384.7 billion in 2024.
PM announces substantial Budget 2025 hastening Malaysia to become Asian economic powerhouse
Datuk Seri Anwar Ibrahim said it would create jobs and also tackle financial leakages to enhance public spending efficiency.